FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1381 October 24, 2002 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Molina, J.-M. PubMed Citation

To the Editor: Molina et al. (June 20 issue)¹ report a two-week study confirming the activity of fumagillin against intestinal microsporidiosis in 12 immunosuppressed adults, 10 of them with advanced human immunodeficiency virus (HIV) infection. Ten patients had partial clinical responses after a median of 10 months; histologic improvement was not documented. It is not certain, however, that these prolonged responses were a result of fumagillin therapy. As the authors note, highly active antiretroviral therapy for HIV infection is also effective against intestinal microsporidiosis (and cryptosporidiosis), probably because it improves immune function.^2,3 Of five of our patients who had had . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.